Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03695380
Title A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

endometrioid ovary carcinoma

ovarian serous carcinoma

fallopian tube cancer

peritoneum cancer

Therapies

Atezolizumab + Cobimetinib + Niraparib

Cobimetinib + Niraparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.